Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma

被引:6
|
作者
Feng, Linxiang [1 ,2 ]
Feng, Zian [1 ,2 ]
Hu, Jie [1 ,2 ]
Gao, Jiahui [1 ,2 ]
Li, Ang [1 ,2 ]
He, Xiaodong [1 ,2 ]
Liu, Liu [1 ,2 ]
Shen, Zuojun [1 ,2 ]
机构
[1] Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Lab Med, Div Life Sci & Med, Hefei, Anhui, Peoples R China
[2] Natl Clin Res Ctr Lab Med, Core Unit, Hefei, Peoples R China
基金
中国国家自然科学基金;
关键词
lung adenocarcinoma; exosome; miRNA; bioinformatics; qRT-PCR; CANCER; PROGRESSION; MIR-619-5P; ANGIOGENESIS; METASTASIS; PROMOTES; BIOLOGY;
D O I
10.3389/fgene.2023.1138230
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction: Lung cancer has long been at the forefront of all cancers in terms of incidence and mortality. Lung adenocarcinoma is the most common type of lung cancer, accounting for 40% of all lung cancer types. Exosomes can act as biomarkers of tumors and thus play an important role.Methods: In this article, high-throughput sequencing of miRNAs in plasma exosomes from lung adenocarcinoma patients and healthy individuals was performed to obtain 87 upregulated miRNAs, which were then combined with data from the GSE137140 database uploaded by others for screening. The database included 1566 preoperative lung cancer patients, 180 postoperative patients, and 1774 non-cancerous controls. We overlapped the miRNAs upregulated in the serum of lung cancer patients in the database relative to those of non-cancer controls and post-operative patients with the upregulated miRNAs obtained from our next-generation sequencing to obtain nine miRNAs. Two miRNAs that were not reported as tumor markers in lung cancer, hsa-miR-4454 and hsa-miR-619-5p, were selected from them and then validated by qRT-PCR, and further analysis of miRNAs was performed using bioinformatics.Results: Real-time quantitative PCR showed that the expression levels of hsa-miR-4454 and hsa-miR-619-5p in plasma exosomes of patients with lung adenocarcinoma were significantly up-regulated. The AUC values of hsa-miR-619-5p and hsa-miR-4454 were 0.906 and 0.975, respectively, both greater than 0.5, showing good performance. The target genes of miRNAs were screened by bioinformatics methods, and the regulatory network between miRNAs and lncRNAs and mRNAs was studied.Discussion: Our work demonstrated that hsa-miR-4454 and hsa-miR-619-5p have the potential to be used as biomarkers for the early diagnosis of lung adenocarcinoma.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Hsa_circ_0070661 inhibits cancer progression through miR-556-5p/TEK axis in lung adenocarcinoma
    Chen, Yupeng
    Wu, Yuanyuan
    CANCER BIOMARKERS, 2023, 37 (01) : 53 - 66
  • [32] Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer
    Liu, Jingjing
    Yoo, Jigeun
    Ho, Jung Yoon
    Jung, Yuyeon
    Lee, Sanha
    Hur, Soo Young
    Choi, Youn Jin
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [33] Circular RNA hsa_circ_0002483 promotes growth and invasion of lung adenocarcinoma by sponging miR-125a-3p
    Wan, Jun
    Ding, Guanggui
    Zhou, Min
    Ling, Xiean
    Rao, Zhanpeng
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [34] Plasma-derived extracellular vesicles miR-335-5p as potential diagnostic biomarkers for fusion-positive rhabdomyosarcoma
    Di Paolo, Virginia
    Paolini, Alessandro
    Galardi, Angela
    Gasparini, Patrizia
    De Cecco, Loris
    Colletti, Marta
    Lampis, Silvia
    Raieli, Salvatore
    De Stefanis, Cristiano
    Miele, Evelina
    Russo, Ida
    Di Ruscio, Valentina
    Casanova, Michela
    Alaggio, Rita
    Masotti, Andrea
    Milano, Giuseppe Maria
    Locatelli, Franco
    Di Giannatale, Angela
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [35] Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinoma
    Wu, Jing
    Feng, Zian
    Wang, Rui
    Li, Ang
    Wang, Hong
    He, Xiaodong
    Shen, Zuojun
    CANCER MEDICINE, 2022, 11 (23): : 4411 - 4421
  • [36] A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma
    Wang, Xian
    Huang, Shan
    Li, Xiaocan
    Jiang, Dongrui
    Yu, Hongzhen
    Wu, Qiang
    Gao, Chaobing
    Wu, Zhengsheng
    PLOS ONE, 2018, 13 (07):
  • [37] Hsa_circ_0001492 regulates the hsa-miR-1455p/ovarian carcinoma immunoreactive antigen domain 2 axis to promote the progression of lung adenocarcinoma
    He, Yuanqiang
    Li, Gang
    Fu, Ran
    Li, Yue
    Wang, Ying
    BIOMOLECULES AND BIOMEDICINE, 2024, : 940 - 953
  • [38] Hsa-miR-584-5p as a novel candidate biomarker in Turkish men with severe coronary artery disease
    Neslihan Coban
    Dilek Pirim
    Aycan Fahri Erkan
    Berkcan Dogan
    Berkay Ekici
    Molecular Biology Reports, 2020, 47 : 1361 - 1369
  • [39] Hsa-miR-584-5p as a novel candidate biomarker in Turkish men with severe coronary artery disease
    Coban, Neslihan
    Pirim, Dilek
    Erkan, Aycan Fahri
    Dogan, Berkcan
    Ekici, Berkay
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (02) : 1361 - 1369
  • [40] Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study
    Switlik, Weronika Zofia
    Karbownik, Michal Seweryn
    Suwalski, Michal
    Kozak, Jozef
    Szemraj, Janusz
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2019, 23 (05) : 353 - 358